1. Home
  2. Labeler Index
  3. Preferred Pharmaceuticals, Inc.
  4. 68788-7520
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 68788-7520 by Preferred Pharmaceuticals, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Pregabalin Capsules 25mg (CV) - pregabalin caps 25mg 30ct

Pregabalin Capsules 25mg (CV) - pregabalin caps 25mg 30ct

This is a description of Pregabalin capsules, which come in 25mg strength and are a generic version of Lyrica. The label warns that it is illegal to transfer this medication to others. Each capsule contains the active ingredient pregabalin. The manufacturer is ScieGen Pharmaceuticals, and the batch number, package size, expiration date, and product number are also listed. There are also some unreadable characters in the text.*

Figure 1 - pregabalin fig01

Figure 1 - pregabalin fig01

Figure 2 - pregabalin fig02

Figure 2 - pregabalin fig02

Figure 3 - pregabalin fig03

Figure 3 - pregabalin fig03

Figure 4 - pregabalin fig04

Figure 4 - pregabalin fig04

Figure 5 - pregabalin fig05

Figure 5 - pregabalin fig05

Figure 6 - pregabalin fig06

Figure 6 - pregabalin fig06

This text seems to be a table of a study or studies concerning the effects of different doses of some medicine compared to a placebo. The table shows the results of at least three different studies (E1, E3, and S5) for which 150mg, 300mg, and 600mg/day of the medicine were administered, as well as the effects of the placebo. The text suggests that the effects of the medicine were statistically significant compared to the placebo, but there is not enough information to say what the medicine was, what it was used for, or what the effects were.*

Figure 7 - pregabalin fig07

Figure 7 - pregabalin fig07

Figure 9 - pregabalin fig08

Figure 9 - pregabalin fig08

Figure 10 - pregabalin fig09

Figure 10 - pregabalin fig09

This appears to be a table that shows the percentages of subjects without LTR (unclear what this refers to) for a treatment called "Progabain" and a placebo over a period of 120 days (from day 0 to day 120). The percentage varies from 0% to 100% for both groups.*

Figure 11 - pregabalin fig10

Figure 11 - pregabalin fig10

Figure 12 - pregabalin fig11

Figure 12 - pregabalin fig11

Percent of subjects improved over a certain period of time is being reported in the provided text. The extent of improvement from Bassine to Week 16 is also mentioned, which is 80%. The rest of the characters don't form readable text.*

Cockcroft and Gault equation - pregabalin formula

Cockcroft and Gault equation - pregabalin formula

This appears to be a formula for calculating the estimated creatinine clearance rate (CLCT) for patients based on their age, weight, and serum creatinine levels. The formula is different for female patients, as the result is multiplied by 0.85. However, the presence of the string "mmmmmmmmm e e" instead of a specific value suggests that there may be an error in the output.*

Chemical Structure - pregabalin str

Chemical Structure - pregabalin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.